2015 Q1 Form 10-Q Financial Statement

#000114420415031656 Filed on May 15, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $41.79K $509.4K
YoY Change -91.8% -45.36%
Cost Of Revenue $10.00K $367.6K
YoY Change -97.28% -35.94%
Gross Profit $30.00K $139.7K
YoY Change -78.53% -61.02%
Gross Profit Margin 71.78% 27.43%
Selling, General & Admin $290.0K $300.0K
YoY Change -3.33% -54.55%
% of Gross Profit 966.67% 214.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.760K $8.659K
YoY Change -45.03% -56.45%
% of Gross Profit 15.87% 6.2%
Operating Expenses $290.8K $298.7K
YoY Change -2.62% -55.09%
Operating Profit -$258.2K -$158.9K
YoY Change 62.47% -48.14%
Interest Expense $50.00K $2.338K
YoY Change 2038.58% -356.64%
% of Operating Profit
Other Income/Expense, Net $51.03K -$12.97K
YoY Change -493.42% -112.36%
Pretax Income -$207.2K -$171.9K
YoY Change 20.52% -14.71%
Income Tax $956.00 $1.206K
% Of Pretax Income
Net Earnings -$208.1K -$173.1K
YoY Change 20.23% -14.11%
Net Earnings / Revenue -497.96% -33.98%
Basic Earnings Per Share
Diluted Earnings Per Share -$308.8K -$257.6K
COMMON SHARES
Basic Shares Outstanding 343.8M shares 328.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $550.0K $570.0K
YoY Change -3.51% -59.57%
Cash & Equivalents $550.0K $495.8K
Short-Term Investments $70.00K
Other Short-Term Assets $120.0K $320.0K
YoY Change -62.5% -57.89%
Inventory $0.00 $16.07K
Prepaid Expenses $100.8K
Receivables $90.00K $212.2K
Other Receivables $120.0K $400.0K
Total Short-Term Assets $880.0K $1.514M
YoY Change -41.88% -44.74%
LONG-TERM ASSETS
Property, Plant & Equipment $10.00K $35.19K
YoY Change -71.58% -81.48%
Goodwill
YoY Change
Intangibles $4.948K
YoY Change
Long-Term Investments
YoY Change
Other Assets $20.00K
YoY Change
Total Long-Term Assets $40.00K $40.14K
YoY Change -0.35% -96.71%
TOTAL ASSETS
Total Short-Term Assets $880.0K $1.514M
Total Long-Term Assets $40.00K $40.14K
Total Assets $920.0K $1.554M
YoY Change -40.81% -60.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $120.0K $193.1K
YoY Change -37.84% -68.35%
Accrued Expenses $620.0K $530.4K
YoY Change 16.89% -65.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $10.00K $20.00K
YoY Change -50.0% -33.33%
Total Short-Term Liabilities $760.0K $792.4K
YoY Change -4.09% -66.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $10.00K
YoY Change -100.0% -75.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $10.00K
YoY Change -100.0% -75.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $760.0K $792.4K
Total Long-Term Liabilities $0.00 $10.00K
Total Liabilities $764.0K $806.4K
YoY Change -5.26% -66.26%
SHAREHOLDERS EQUITY
Retained Earnings -$53.96M -$52.26M
YoY Change 3.25%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $160.0K $750.0K
YoY Change
Total Liabilities & Shareholders Equity $920.0K $1.550M
YoY Change -40.65% -60.86%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$208.1K -$173.1K
YoY Change 20.23% -14.11%
Depreciation, Depletion And Amortization $4.760K $8.659K
YoY Change -45.03% -56.45%
Cash From Operating Activities $288.4K -$44.99K
YoY Change -741.09% -83.19%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $90.00K
YoY Change -100.0%
Cash From Investing Activities $0.00 $87.48K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $195.0K $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 190.0K -$9.981K
YoY Change -2003.62% 40.68%
NET CHANGE
Cash From Operating Activities $288.4K -$44.99K
Cash From Investing Activities 0.000 $87.48K
Cash From Financing Activities 190.0K -$9.981K
Net Change In Cash $288.4K $32.51K
YoY Change 787.31% -111.83%
FREE CASH FLOW
Cash From Operating Activities $288.4K -$44.99K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
53506353 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53957865 USD
CY2015Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
0 USD
CY2014Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
25000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
120979 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1036125 USD
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
343774050 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
343774050 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
339374050 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
339374050 shares
CY2015Q1 us-gaap Revenues
Revenues
41794 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
139737 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
298655 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
290830 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-158918 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-258191 USD
CY2014Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2338 USD
CY2015Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-280 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1802 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2014Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
CY2015Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
51310 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12971 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
51030 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-171889 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-207161 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1206 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
956 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-173095 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-208117 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
328874050 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
341341828 shares
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8659 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4760 USD
CY2014Q1 payd Unrealized Gain On Investments
UnrealizedGainOnInvestments
-2800 USD
CY2015Q1 payd Unrealized Gain On Investments
UnrealizedGainOnInvestments
0 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12668 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
50333 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-128417 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
75 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14761 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
59632 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7827 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
2041 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
0 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-307269 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-94536 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
91457 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-904 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
38734 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-110 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-44993 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-288447 USD
CY2014Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
9981 USD
CY2015Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
4296 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
195000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-9981 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
190704 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
32508 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-97743 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
463285 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
495793 USD
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
596 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
280 USD
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Use of Estimates</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates made by the Company&#8217;s management include, but are not limited to the collectability of accounts receivables and other receivables, the valuation of inventories, the recoverability of long-lived assets, the valuation of deferred tax assets and liabilities and the estimated fair value of the royalty and advance guarantees and share-based transactions. Actual results could materially differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Reclassifications</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Certain reclassifications have been made to the prior period financial statement presentation to conform to the current year financial statement presentation. The reclassifications did not have any effect on reported net losses for any period presented.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Concentration of Credit Risk</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company maintains cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. At March 31, 2015, the Company had amounts in these accounts in excess of the FDIC limit. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to these deposits. Management believes that it has invested in high credit quality institutions for which the Company has not experienced any loss in its accounts and believes it is not exposed to any significant credit risk related to these accounts.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company extends credit based on an evaluation of the customer's financial condition, generally without requiring collateral. Exposure to losses on receivables is principally dependent on each customer's financial condition. The Company monitors its exposure for credit losses and maintains allowances for anticipated losses. Although the Company expects to collect amounts due, actual collections may differ from the estimated amounts. At both March 31, 2015 and December 31, 2014, the Company has recorded an allowance for doubtful accounts of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">38,609</font></font>, respectively.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> For the three months ended March 31, 2015, no revenues from an individual client accounted for more than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of total revenues. For the three months ended March 31, 2014, revenues from one client accounted for approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 86</font>% of total revenues. These revenues were generated from the sales of our line of AuctionInc products, tour merchandise, VIP services, and merchandising and fulfillment services.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
38609 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
38609 USD
CY2014Q1 us-gaap Advertising Expense
AdvertisingExpense
940 USD
CY2015Q1 us-gaap Advertising Expense
AdvertisingExpense
6224 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11962000 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3535000 shares
CY2015Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1115 USD
CY2014Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2019 USD
CY2015Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
80572 USD
CY2014Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
80572 USD
CY2015Q1 payd Stock Payment Guarantee Liabilities Current
StockPaymentGuaranteeLiabilitiesCurrent
503422 USD
CY2014Q4 payd Stock Payment Guarantee Liabilities Current
StockPaymentGuaranteeLiabilitiesCurrent
554732 USD
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
36696 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
36696 USD
CY2015Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
621805 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
674019 USD
CY2015Q1 us-gaap Other Receivables
OtherReceivables
120338 USD
CY2014Q4 us-gaap Other Receivables
OtherReceivables
120338 USD
CY2015Q1 us-gaap Liabilities
Liabilities
763990 USD
CY2014Q4 us-gaap Liabilities
Liabilities
915146 USD
CY2014Q1 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
2800 USD
CY2015Q1 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
0 USD
CY2014Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
87482 USD
CY2015Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
87482 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2015Q1 us-gaap Share Price
SharePrice
0.12
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015Q1 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
less than a 50% likelihood
CY2015Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
19702 USD
CY2014Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
23387 USD
CY2014Q1 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
3748 USD
CY2015Q1 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0 USD
CY2014Q1 payd Other Accounts Receivable Writeoffs
OtherAccountsReceivableWriteoffs
55618 USD
CY2015Q1 payd Other Accounts Receivable Writeoffs
OtherAccountsReceivableWriteoffs
0 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
3748 USD
CY2015Q1 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
0 USD
CY2015Q1 us-gaap Fdic Indemnification Asset
FDICIndemnificationAsset
250000 USD
CY2015Q1 payd Common Stock Held For Sale
CommonStockHeldForSale
2528091 shares
CY2014Q4 payd Common Stock Held For Sale
CommonStockHeldForSale
2528091 shares
CY2015Q1 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 USD
CY2014Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
55618 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2014Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-214759 USD
CY2015Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 USD
CY2014Q1 us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
0 USD
CY2015Q1 us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
3685 USD
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
500000 shares
CY2014Q1 us-gaap Stock Issued1
StockIssued1
0 USD
CY2015Q1 us-gaap Stock Issued1
StockIssued1
25000 USD
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
195000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
288447 USD
CY2014Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2015Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2014Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
500000 shares

Files In Submission

Name View Source Status
0001144204-15-031656-index-headers.html Edgar Link pending
0001144204-15-031656-index.html Edgar Link pending
0001144204-15-031656.txt Edgar Link pending
0001144204-15-031656-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
payd-20150331.xml Edgar Link completed
payd-20150331.xsd Edgar Link pending
payd-20150331_cal.xml Edgar Link unprocessable
payd-20150331_def.xml Edgar Link unprocessable
payd-20150331_lab.xml Edgar Link unprocessable
payd-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlogo.jpg Edgar Link pending
v409541_10q.htm Edgar Link pending
v409541_ex31-1.htm Edgar Link pending
v409541_ex31-2.htm Edgar Link pending
v409541_ex32.htm Edgar Link pending